Goldratt teaches that systems should be judged by their output, addressed at the highest level, and constraints should be removed. For a patient that has the disease, some treatment options are emerging.

Remdesivir: Nucleotide analog

Produced by Gilead, this class of drug has existed for some time and has been shown to perform well against RNA virsues.

Camostat: Serine protease inhibitor

A German research team found that a cell line was susceptible to Sars-2, and then showed that Camostat was capable of slowing and perhaps stopping the damage created by the virus.